AGA Medical Corporation partnered with MSC to develop and deliver a streamlined certification training program for the AMPLATZER^® Septal Occluder.

Bard Peripheral Vascular, a leader in the development of products for End Stage Renal Disease (ESRD), chose MSC's SimSuite simulation technology platform to train physicians on the BARD^® FLAIR^® Endovascular Stent Graft,
(learn more)

Bard Peripheral Vascular, a leader in the development of products for End Stage Renal Disease (ESRD), chose MSC's SimSuite simulation technology platform to train physicians on the BARD^® FLAIR^® Endovascular Stent Graft, the only FDA-approved stent graft indicated for use in the treatment of stenosis at the venous anastomosis of ePTFE or other synthetic arteriovenous (AV) access grafts. The BARD^® FLAIR^® Endovascular Stent Graft is designed for dialysis patients that have grafts connecting the venous and arterial systems in the upper or lower arms. MSC has designed simulation courseware around various cases to apply this device properly by the correct recognition of the problems and the correct placement and delivery of the devices.
(close)

The Boston Scientific Corporation (BSC) Neuromodulation division has used the MSC training solutions to successfully reduce the need for cadavers used in the training for Spinal Cord Stimulation devices implanted in patients with chronic pain. Consistent delivery of training creates a foundation for companies such as BSC to measure performance and potentially certify the physician community based on their proficiency in this practice.
(learn more)

The Boston Scientific Corporation (BSC) Neuromodulation division has used the MSC training solutions to successfully reduce the need for cadavers used in the training for Spinal Cord Stimulation devices implanted in patients with chronic pain. Consistent delivery of training creates a foundation for companies such as BSC to measure performance and potentially certify the physician community based on their proficiency in this practice. BSC has also used the SimSuite high fidelity endovascular simulation platform to introduce new medical devices and procedures into the physician and healthcare community through a clinically-based education and training model. MSC has developed and delivered an experience-based training program for the FilterWire EX^™ and Rotablator^® Rotational Atherectomy product lines to achieve a fast time-to-market and significant ROI. Using this unique mobile marketing and distribution method, the Boston Scientific SimSuite bus program successfully created a highly recognizable industry brand.
(close)

Edwards Lifesciences has worked with MSC since 2004 on a comprehensive procedure training program for its transcatheter heart valve technology.
(learn more)

Edwards Lifesciences has worked with MSC since 2004 on a comprehensive procedure training program for its transcatheter heart valve technology. The program was designed to train surgeons and cardiologists during U.S., Canadian and European clinical trials. With CE Mark approval for the transcatheter heart valve in Europe, the training program is now focused on providing physicians with commercial product training.
(close)

MSC has partnered with biomeasurement technology leader Hutchinson Technology to develop and deliver simulation-based education around the InSpectra^™ StO₂ Tissue Oxygenation Monitor.
(learn more)

MSC has partnered with biomeasurement technology leader Hutchinson Technology to develop and deliver simulation-based education around the InSpectra^™ StO₂ Tissue Oxygenation Monitor. Effective training is essential to: understanding how StO₂ differs from traditional vital signs; and, accurately interpreting InSpectra StO₂ Measurements for early detection of inadequate tissue perfusion. The training, delivered by MSC clinical educators using a high-fidelity human patient simulator, presents an actual patient case that allows clinicians to practice using InSpectra StO₂ to screen and monitor tissue oxygenation in trauma and critical care patients.
(close)

Medtronic, a global leader in life-changing medical technologies, selected MSC in 2008 as its preferred provider of simulation services. MSC has partnered with Medtronic to develop a simulation-based training program for the Talent™ Thoracic Stent Graft.

Spectranetics, a leader in development and distribution of single-use medical devices used in minimally invasive procedures within the cardiovascular system, partnered with MSC to develop and distribute the customized Laser Lead Extraction Simulation using MSC’s SimSuite simulation technology platform.